Evid Invest
Who owns INTSWhat INTS owns — n/a

Who owns Intensity Therapeutics, Inc.?

Institutional ownership of INTS from SEC Form 13F filings across 13 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.

13

13F holders

$2.3M

value, 2026 filers

22%

of shares outstanding (594,531 sh)

5

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of INTS's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1KMT WEALTH MANAGEMENT, LLCNEW496,493$2.0M1.7%18.4%new
2VANGUARD CAPITAL MANAGEMENT LLC26,569$108,9330.0%1%-21.1%
3GEODE CAPITAL MANAGEMENT, LLC22,787$93,4260.0%0.8%-12.4%
4FNY Investment Advisers, LLCNEW22,000$900.0%0.8%new
5Mesirow Financial Investment Management, Inc.14,118$57,8840.0%0.5%0.0%
6VANGUARD FIDUCIARY TRUST CO9,121$37,3960.0%0.3%0.0%
7Tower Research Capital LLC (TRC)1,984$8,1340.0%0.1%+2861.2%
8NewEdge Advisors, LLCNEW1,148$4,7070.0%0%new
9OSAIC HOLDINGS, INC.200$8200.0%0%0.0%
10MERCER GLOBAL ADVISORS INC /ADVNEW48$1970.0%0%new
11BARCLAYS PLCNEW42$1720.0%0%new
12MORGAN STANLEY20$820.0%0%0.0%
13UBS Group AG1$40.0%0%-99.5%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.